Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
31,523,534
-
Total 13F shares
-
1,897,106
-
Share change
-
+240,831
-
Total reported value
-
$1,212,138
-
Price per share
-
$0.64
-
Number of holders
-
17
-
Value change
-
+$145,339
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) as of Q3 2024
As of 30 Sep 2024,
ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,897,106 shares.
The largest 10 holders included
INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF MONTREAL /CAN/, NORTHERN TRUST CORP, CIBC WORLD MARKET INC., Gradient Capital Advisors, LLC, Federation des caisses Desjardins du Quebec, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, and Rathbones Group PLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.